The aim of this trial is to investigate the effects of a six-week exercise training program on patients with rheumatoid arthritis. The main outcomes will be disease activity, inflammation, fitness and muscle strength. This trial is recruiting in Belfast, Northern Ireland.

This paper reviewed various strategies of preventing resistance to endocrine therapy. 

The aim of this phase 2 clinical trial is to measure the effectiveness and safety of the drug GDC-0853 in patients with rheumatoid arthritis who have not responded well to other treatments. The main outcomes to be investigated are improvement in pain, function and disease activity, as well as side effects experienced.

This study evaluated the impact of breast cancer subtypes on disease prognosis in patients with metastatic breast cancer (cancer that has spread outside the breasts to the other parts of the body).

The authors aimed to determine whether or not a hormone called melatonin could positively influence the quality of life of women with breast cancer.

This study evaluated survival rates after a local recurrence (return of the cancer close to the place of the initial cancer) in young breast cancer patients treated with breast conserving surgery.

The aim of this article was to discuss the way in which the latest results on cancer DNA research apply to early-stage breast cancer. Genome analysis is highly likely to play a growing role in the future but more clinical trials are needed.

The authors aimed to determine the prognostic (treatment outlook) value of genetic expression (the expression of genes) on breast cancer survival.

This paper studied the role of yes-associated protein in breast cancer.

This study looked at women with breast cancer and the BRCA 1 or 2 gene mutations. The authors evaluated the overall survival (the percentage of patients surviving after a defined time from diagnosis or treatment) for these women after removal of both breasts.